Stevanato Group SpA
Suletud
SektorTervishoid
16.96 -0.35
Ülevaade
Aktsiahinna muutus
24h
Min
16.9
Max
17.09
Sissetulek | -7.9M 39M |
|---|---|
Müük | -70M 274M |
P/E Sektori keskmine | 31.288 49.052 |
Aktsiakasum | 0.13 |
Kasumimarginaal | 14.343 |
Töötajad | 6,010 |
EBITDA | -25M 65M |
Soovitused | Tugev "osta" hinnang |
|---|---|
12 kuu keskmine prognoos | +28.81% upside |
Järgmine tulemuste avaldamine | 4. aug 2026 |
|---|
Turukapital | 183M 5B |
|---|---|
Eelmine avamishind | 17.31 |
Eelmine sulgemishind | 16.96 |
Uudiste sentiment
By Acuity
50%
50%
146 / 342 Pingereas Healthcare
Stevanato Group SpA Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Ettevõttest Stevanato Group SpA
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
